Rybelsus 3mg

Rybelsus 3mg

Rybelsus is an oral prescription medication primarily used for the treatment of type 2 diabetes mellitus in adults. It contains the active ingredient semaglutide, which belongs to the class of GLP-1 receptor agonists (glucagon-like peptide-1 analogues). Unlike traditional injectable GLP-1 drugs, Rybelsus is the first FDA-approved oral GLP-1 therapy, providing patients with a convenient tablet option for diabetes management. It is manufactured by Novo Nordisk.

Order azithromycin online

Mechanism of Action

Although semaglutide is not insulin, it mimics the action of a natural hormone called GLP-1 (glucagon-like peptide-1). By binding to GLP-1 receptors, it helps regulate blood sugar levels through several key mechanisms:

• Stimulates insulin release when blood sugar is high.

• Reduces glucagon secretion, which lowers glucose production in the liver.

• Slows gastric emptying, improving post-meal glucose control.

• Acts on the brain to reduce appetite, which can support weight loss.

Through these actions, Rybelsus improves blood sugar control and may also provide cardiovascular benefits in patients with type 2 diabetes and heart disease.

Buy Tadaga Super 60

Indications

Rybelsus 3mg is prescribed for the following condition:

• Type 2 Diabetes Mellitus:
  It is used to improve glycemic control in adults when diet and exercise alone are not enough.

⚠️ It is not indicated for type 1 diabetes or diabetic ketoacidosis.

Buy Gabapentin

Dosage and Administration

• The 3mg dose of Rybelsus is a starting dose.

• It is taken once daily for the first 30 days only, to allow the body to adjust.

• After 30 days, patients are typically increased to 7mg once daily, and if further control is needed, up to 14mg once daily.

How to take Rybelsus 3mg:

• Take on an empty stomach, at least 30 minutes before eating, drinking, or taking any other oral medications.

• Swallow the tablet whole with no more than 4 ounces of plain water.

• Do not crush, split, or chew the tablet.